Australian woman dies after consuming too much caffeine
A Melbourne woman who waited more than seven hours for an ambulance died alone in her apartment from a caffeine overdose, despite calling for help the night before.
Christina Lackmann, 32, contacted emergency services from her Caulfield North home on April 20, 2021, describing symptoms including dizziness, numbness, and feeling light-headed. She was found dead the next morning.
Coroner Catherine Fitzgerald found the aspiring cancer researcher would likely have survived had paramedics arrived sooner.
Ms Lackmann made a triple zero call at 7.49pm, telling a handler she was feeling unwell and was unable to get up from the floor.
The coroner has highlighted problems with the response to the call, including not transferring Ms Lackmann to a health practitioner for further assessment.
At no point did she disclose she had taken caffeine tablets and was categorised as a non-acute/non-urgent Code 3.
She was told to keep her phone line free and Ambulance Victoria staff attempted to call her back 14 times.
Ms Lackmann was also sent one text but all attempts to contact her were left unanswered.
Christina Lackmann (pictured) died in the early hours of April 22, 2021 after calling for help the previous evening when she felt sick, dizzy and was unable to get up off the floor
Caffeine tablets were delivered to Ms Lackmann's apartment on the same day she made the triple-zero call. The tablets nor their packaging was found in the apartment (stock)
Ms Lackmann, who was studying for her final semester of a biomedical sciences degree, had called her mother Beate Lackmann earlier in the evening, but she was unable to answer the call.
Beate told the inquest she attempted to call her daughter back at 6.30pm. She did not answer but told her mum she was 'ok' during a text exchange.
Her case priority was upgraded an hour after her triple-zero call, which should have improved her chances of having an ambulance dispatched imminently.
However, two ambulances that were subsequently assigned to her were diverted to greater-priority cases.
Seven hours and 11 minutes after her call for help , paramedics gained access to Ms Lackmann's apartment shortly before 3am.
She was pronounced dead soon after having died alone on her bathroom room.
It was later discovered via an email on Ms Lackmann's phone that she an iHerb order of caffeine tablets had been delivered to her apartment on the day she made the triple-zero call.
Ms Lackmann (pictured with her mother Beate Lackmann) did not respond to Ambulance Victoria staff's 14 attempts to call her back following her initial triple-zero call
The tablets nor their packaging was found in the apartment.
A post-mortem found Ms Lackmann had ingested a very high concentration of caffeine.
Associate Professor Narendra Gunja, a specialist medical practitioner in clinical and forensic toxicology, said caffeine overdoses can become fatal within eight hours of ingestion.
He said if paramedics had been dispatched to Ms Lackmann and she had been hospitalised soon after her call for help, she would have likely received proper medical treatment.
Ms Lackmann would likely have been asked what she had ingested and treated for a caffeine overdose.
He said he was unable to suggest an exact time when her death was preventable because it was not clear when Ms Lackmann took the tablets nor how large the dose was.
The Victorian Institute of Forensic Medicine's chief toxicologist, Dimitri Gerostamoulos, said the concentration of caffeine found in Ms Lackmann's blood could not be achieved by drinking coffee.
Ms Fitzgerald slammed Ambulance Victoria in her ruling and said the wait time was 'unacceptable', with 80 per cent of their vehicles unable to respond to emergencies as they were ramped up at hospitals.
Ambulance ramping involves paramedics being forced to wait to offload patients at emergency departments.
Following the inquest, Ambulance Victoria undertook an internal review and made changes to its procedures.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
10 minutes ago
- Sky News
Patients filming NHS medical treatment for TikTok and Instagram, radiographers say
Patients are filming their NHS medical treatment for TikTok and Instagram, potentially putting them and others at risk, medical professionals have said. Ashley d'Aquino, a therapeutic radiographer working in London, said a rising number of patients are choosing to film their treatment for social media. The Society of Radiographers (SoR) said it is causing healthcare staff unnecessary anxiety when they are trying to carry out their job and is putting patient confidentiality at risk. The organisation added that distracting staff and making them uncomfortable could compromise the delivery of their medical treatment. The SoR is calling for the NHS to implement policies to prevent patients from photographing or filming clinical procedures without permission. Ms d'Aquino, who is a union rep, told the SoR's annual delegates' conference that members of staff had approached her over patients recording some of their cancer treatment. She said one worker agreed to take photos for a patient, "but when the patient handed over her phone, the member of staff saw that the patient had also been covertly recording her to publish on her cancer blog". "As NHS staff, we wear name badges, so our names will be visible in any video. It makes people feel very uncomfortable and anxious," Ms d'Aquino explained. Filming treatments also puts patient confidentiality at risk, another worker explained. A radiology department assistant from the south coast said she was using a cannula on a cancer patient when the patient's 19-year-old daughter started filming the procedure without asking for permission. "She wanted to record the cannulation because she thought it would be entertaining on social media," she said. But in the next bay, a patient was having consent taken for a virtual colonoscopy, which is "an invasive and potentially embarrassing procedure". The consent, including names and dates of birth, could have been recorded on the video, putting the patient at risk. "There are people who come into our department who have a limited social media presence because of risks to their safety. Patients filming make them feel unsafe in their own hospital," she said. The department assistant said she had sleepless nights worrying about whether she did her job properly in this situation. Filming treatments affects all healthcare workers, according to Dean Rogers, SoR director of industrial strategy and member relations. He said all hospital trusts should have policies in place around patients taking photos and filming procedures to stop people filming without staff knowledge and permission. "Hospitals need to ensure that they meet the needs of patients while also looking after staff members' wellbeing," Mr Rogers said. "And, in this case, safeguarding the one simultaneously safeguards the other - allowing healthcare professionals to do their job in safety, while also protecting patients' privacy and helping them to receive the best possible care." Ms d'Aquino acknowledged that there may be some valid reasons for patients to record medical conversations, for example, to "enhance their understanding and retention of medical information" by making audio recordings of consultations.
The Independent
an hour ago
- The Independent
Medics urge NHS TikTok policy amid privacy concerns
The Society of Radiographers (SoR) has raised concerns about patients recording NHS medical treatments for platforms like TikTok and Instagram, citing risks to staff and other patients. The SoR advocates for clear NHS policies to prevent patients from filming clinical procedures without prior permission, to ensure a safer environment. Ashley d'Aquino, a therapeutic radiographer, noted an increase in patients filming cancer treatments, causing anxiety among staff due to potential privacy breaches and distractions. One incident involved a cancer patient's daughter filming a cannulation without permission, raising concerns about recording other patients' private information. Dean Rogers of the SoR emphasised the need for hospital trusts to implement policies that balance patient needs with staff wellbeing, ensuring privacy and optimal care.
Daily Mail
2 hours ago
- Daily Mail
Weight loss jabs like Mounjaro now linked to more than a HUNDRED deaths, the UK's drug watchdog confirms
Slimming jabs like Mounjaro and Wegovy have been linked to more than 100 deaths in Britain, it was revealed today. None of the fatalities, which have all been reported since the jabs were licensed for use in the UK, are proven to have been caused directly by the drugs. However, health chiefs tasked with policing the safety of medicines admit reports of side effects indicate 'a suspicion' they may have been to blame. A total of 111 deaths were logged with the regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), up to and including May 29. These are based on patients' families or healthcare workers informing the MHRA of a suspected fatal reaction to the drugs, known as glucagon-like peptide-1 receptor agonists (GLP-1RAs). It comes just months after the death Scottish nurse Susan McGowan, 58, who experienced multiple organ failure, septic shock and pancreatitis after taking just two doses of Mounjaro. Hers is the only confirmed fatality linked to the jabs in the UK. But it comes at a time when ministers are planning to rollout the jabs—described as game changers in the fight against obesity— to even more Britons. The deaths may also be caused by underlying medical conditions or other medications taken at the same time and therefore can be coincidental the MHRA told trade magazine Chemist+Druggist. Officials use the MHRA's 'Yellow Card' database, set-up in the wake of the 1960s thalidomide scandal, to track the safety of medications currently in use in Britain. Although almost impossible to prove, the system allows doctors, pharmacists and patients to report adverse reactions they believe are linked to medications and allows officials to uncover potential patterns. The weight-loss medication linked to the most deaths, in the system was liraglutide—sold under the brand name Saxenda—with 37 reports of a fatal outcome. In second place was tirzepatide—sold as Mounjaro and once hailed the 'King Kong' of slimming jabs—with 33 deaths. And in third place was semaglutide—the active ingredient in the weight loss jab Wegovy as well diabetes drug Ozempic—which was linked to 30 deaths. A further seven reports were liked to dulaglutide—known as Trulicity—and five to lixisenatide—which has the trade name Lyxumia. Of the total fatal reports, 32 involved jabs indicated for 'weight management alone or 'only licensed for weight management—Mounjaro, Saxenda, Wegovy'. Meanwhile, 40 reports related to drugs with an indication for 'diabetes alone'. Another nine referred to patients getting the jab for 'both weight management or diabetes'. While 30 reported a fatal outcome 'with an indication other than weight management or diabetes, or where no indication has been reported', the watchdog told Chemist+Druggist. Last year, medics warned they were seeing a wave of patients of healthy weight taking the drugs in a bid to become 'beach-body ready'. Such patients, mostly young women, were landing in A&E after obtaining the drugs online under false pretences. Currently, patients can obtain the drugs from many chemists by filling in online forms with details of their weight and height and submitting photographs of themselves. However, experts and organisations such as the Society for Acute Medicine have called for tighter restrictions on how Ozempic, Mounjaro and other weight-loss products are prescribed. A spokesperson for Lilly UK, the makers of Mounjaro, said patient safety is its 'top priority'. It added: 'Regulatory agencies conduct extensive independent assessments of the benefits and risks of every new medicine and Lilly is committed to continually monitoring, evaluating, and reporting safety data.' 'If anyone is experiencing side effects when taking any Lilly medicine, they should talk to their doctor or other healthcare professional.' There has been growing concern after reports of side effects from the drugs. These include including nausea, vomiting, diarrhoea, bone fractures, tooth damage, severe anxiety and depression. Earlier this month, women reported terrifying mental health side effects after using Mounjaro. The jab, along with similar treatments such as Ozempic and Wegovy, can help patients lose up to 15 per cent of their body weight in a year.
